|

Tamoxifen 20 mg Clinical Trials

4 actively recruiting trials across 1 location

▲ +1 trial since June 2026

Pipeline

Phase 2: 4

Top Sponsors

  • SOLTI Breast Cancer Research Group1
  • Institut Cancerologie de l'Ouest1
  • Fudan University1
  • Eli Lilly and Company1

Indications

Other3 trials

Elacestrant With/Without Triptorelin in Premenopausal Women With Luminal Breast Cancer
Phase 2
Impact of Neoadjuvant Hormonal Therapy on the Surgical Management of Extensive Ductal Carcinomas in Situ
Phase 2
Tamoxifen for Advanced Solid Pseudopapillary Tumor of the Pancreas
Phase 2

Birmingham, Alabama1 trial

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

University of Alabama at Birmingham

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.